ARYx Therapeutics, Inc. (ARYX)

ARYx Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005
Period Ending	Sep 30, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007	Dec 31, 2006	Dec 31, 2005
Cash & Equivalents	2.95	7.41	36	55.48	18.66	12.46
Short-Term Investments	-	0.35	8.59	7.64	31.65	13.89
Cash & Short-Term Investments	2.95	7.76	44.59	63.12	50.31	26.34
Cash Growth	-79.18%	-82.59%	-29.36%	25.46%	90.99%	-
Prepaid Expenses	0.58	0.9	1.11	1.63	1.1	1.38
Restricted Cash	0.15	0.15	0.15	0.15	-	-
Total Current Assets	3.68	8.81	45.85	64.9	51.41	27.72
Property, Plant & Equipment	1.58	2.26	3.2	3.66	4.17	4.14
Other Long-Term Assets	0.71	1.34	2.1	1.07	1.18	1.45
Total Assets	5.97	12.41	51.15	69.63	56.76	33.31
Accounts Payable	0.23	0.69	2.45	1.37	0.69	0.66
Accrued Expenses	0.73	2.81	4.83	4.31	2.56	4.49
Current Portion of Long-Term Debt	6.83	4.85	3.4	3.54	3.2	2.24
Current Unearned Revenue	-	-	-	3.91	3.9	-
Other Current Liabilities	-	0.33	0.33	0.33	1.19	0.35
Total Current Liabilities	7.79	8.68	11.02	13.46	11.53	7.75
Long-Term Debt	4.75	5.28	10.16	3.44	6.68	8.92
Long-Term Unearned Revenue	-	-	-	15.58	19.48	-
Other Long-Term Liabilities	1.17	1.36	2.56	1.79	2.12	2.38
Total Liabilities	13.71	15.32	23.73	34.28	39.81	19.05
Common Stock	0.03	0.03	0.03	0.02	0	0
Additional Paid-In Capital	191.88	184.17	181.29	158.05	1.45	1.04
Retained Earnings	-199.65	-187.11	-153.94	-122.72	-95.16	-67.84
Comprehensive Income & Other	-	-	0.05	-	-0	-0.3
Total Common Equity	-7.74	-2.92	27.42	35.35	-93.71	-67.09
Shareholders' Equity	-7.74	-2.92	27.42	35.35	16.95	14.27
Total Liabilities & Equity	5.97	12.41	51.15	69.63	56.76	33.31
Total Debt	11.57	10.13	13.56	6.98	9.88	11.17
Net Cash (Debt)	-8.62	-2.37	31.02	56.14	40.43	15.18
Net Cash Growth	-	-	-44.73%	38.84%	166.42%	-
Net Cash Per Share	-0.28	-0.09	1.64	16.78	39.72	16.68
Filing Date Shares Outstanding	33.46	28.53	27.34	17.66	1.12	1
Total Common Shares Outstanding	33.46	28.03	27.34	17.65	1.06	1
Working Capital	-4.11	0.13	34.83	51.44	39.88	19.97
Book Value Per Share	-0.23	-0.10	1.00	2.00	-88.71	-67.41
Tangible Book Value	-7.74	-2.92	27.42	35.35	-93.71	-67.09
Tangible Book Value Per Share	-0.23	-0.10	1.00	2.00	-88.71	-67.41
Machinery	-	3.72	3.7	3.1	2.74	2.05
Leasehold Improvements	-	2.97	2.94	2.9	2.81	2.75

Source: S&P Global Market Intelligence. Standard template. Financial Sources.